Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
Completed
Actelion
Phase 3
This study will assess the efficacy and safety of ACT-129968 in adolescent, adult and elderly
patients with seasonal allergic rhinitis, due to mountain cedar pollen.
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
Completed
Idorsia Pharmaceuticals Ltd.
Phase 3
This study will assess the efficacy and safety of ACT-129968 in adolescent, adult and elderly
patients with seasonal allergic rhinitis, due to mountain cedar pollen.
A Study to Assess the Tolerability, Safety, Pharmacodynamics, and Pharmacokinetics of Ascending Single Doses (Including Food Interaction) and Ascending Multiple Doses of ACT-453859, and Multiple Doses of Setipiprant (ACT-129968)
Completed
Actelion
Phase 1
This is a three-part study to assess the tolerability, safety, pharmacodynamics, and
pharmacokinetics of ascending single doses (including food interaction) of ACT-453859 in
healthy male subjects, of ascending multiple doses of ACT-453859 in healthy male and female
subjects, and of multiple doses of setipiprant (ACT-129968) in healthy male and female
subjects.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
